KR20130008002A - 코어 안정화 마이크로캡슐, 이의 제조방법 및 이의 용도 - Google Patents

코어 안정화 마이크로캡슐, 이의 제조방법 및 이의 용도 Download PDF

Info

Publication number
KR20130008002A
KR20130008002A KR1020127009212A KR20127009212A KR20130008002A KR 20130008002 A KR20130008002 A KR 20130008002A KR 1020127009212 A KR1020127009212 A KR 1020127009212A KR 20127009212 A KR20127009212 A KR 20127009212A KR 20130008002 A KR20130008002 A KR 20130008002A
Authority
KR
South Korea
Prior art keywords
microcapsules
metal oxide
agents
mixtures
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020127009212A
Other languages
English (en)
Korean (ko)
Inventor
오퍼 토레다노
하임 발- 시만토브
하난 서트추크
샤론 파이어맨-쇼레쉬
도리트 마르코-다간
Original Assignee
솔-겔 테크놀로지스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔-겔 테크놀로지스 리미티드 filed Critical 솔-겔 테크놀로지스 리미티드
Publication of KR20130008002A publication Critical patent/KR20130008002A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020127009212A 2009-12-31 2010-12-30 코어 안정화 마이크로캡슐, 이의 제조방법 및 이의 용도 Withdrawn KR20130008002A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29159409P 2009-12-31 2009-12-31
US61/291,594 2009-12-31
PCT/IL2010/001092 WO2011080741A2 (en) 2009-12-31 2010-12-30 Core stabilized microcapsules, method of their preparation and uses thereof

Publications (1)

Publication Number Publication Date
KR20130008002A true KR20130008002A (ko) 2013-01-21

Family

ID=44226918

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127009212A Withdrawn KR20130008002A (ko) 2009-12-31 2010-12-30 코어 안정화 마이크로캡슐, 이의 제조방법 및 이의 용도

Country Status (13)

Country Link
US (2) US10512796B2 (https=)
EP (1) EP2467132B1 (https=)
JP (1) JP5934107B2 (https=)
KR (1) KR20130008002A (https=)
CN (1) CN102596186B (https=)
AU (1) AU2010337830B2 (https=)
BR (1) BR112012012023A2 (https=)
CA (1) CA2773544C (https=)
EA (1) EA201200347A1 (https=)
ES (1) ES2611499T3 (https=)
MX (1) MX344128B (https=)
WO (1) WO2011080741A2 (https=)
ZA (1) ZA201203582B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021006615A1 (ko) * 2019-07-09 2021-01-14 주식회사 엘지생활건강 화장품용 캡슐

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
JP2011529392A (ja) 2008-07-31 2011-12-08 ゾル−ゲル テクノロジー リミテッド 活性成分および金属酸化物シェルを含むマイクロカプセル、その製造方法およびその使用
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
BR112012012023A2 (pt) 2009-12-31 2016-05-17 Sol Gel Technologies Ltd processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas
ES2902498T3 (es) 2011-06-29 2022-03-28 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
EP2822743A1 (en) * 2012-04-18 2015-01-14 Rohm and Haas Company Wax-biocide wood treatment
US10806697B2 (en) * 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN102726383B (zh) * 2012-07-05 2015-03-18 常州美胜生物材料有限公司 一种缓释型害虫引诱剂微胶囊及其制备方法
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
EP2925296B1 (en) * 2012-11-27 2021-01-06 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
CN104624125B (zh) * 2013-11-11 2018-03-02 中国人民银行印制科学技术研究所 一种光致变色双壳微胶囊及其制备方法和应用
CN103908912A (zh) * 2014-03-13 2014-07-09 安徽明讯新材料科技有限公司 一种相变恒温配胶容器
US9480960B2 (en) * 2014-12-01 2016-11-01 National Chung Shan Institute Of Science And Technology Process for preparing phase change microcapsule having thermally conductive shell
US10383798B2 (en) * 2015-05-13 2019-08-20 Conopco, Inc. Benefit delivery particle comprising a phenylalanine chitosan salt
WO2017029665A1 (en) 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
KR101779846B1 (ko) 2015-08-31 2017-10-10 주식회사 티케이케미칼 나노다공성을 갖는 서방성 미분말과 그 제조방법
CN105754554B (zh) * 2016-02-02 2019-02-19 中南林业科技大学 一种含纳米TiO2的纤维素基低温相变储能微胶囊及其制备方法
EP3419659A1 (en) 2016-02-23 2019-01-02 The Regents of the University of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
ES2979065T3 (es) * 2016-03-04 2024-09-24 Arkema Inc Encapsulación de peróxidos para aplicaciones cutáneas
CN105797659B (zh) * 2016-04-08 2018-12-14 东南大学 一种二氧化硅壳聚糖双壳储热微胶囊的制备方法
CA3069359C (en) * 2017-07-12 2023-01-10 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
EP3651755A4 (en) 2017-07-12 2021-03-24 Sol-Gel Technologies Ltd. METHODS AND COMPOSITIONS FOR TREATMENT OF ACNE
CN107213806B (zh) * 2017-07-13 2018-03-06 广州达济医学科技有限公司 一种用于滤除白细胞的滤膜及其制备方法
US11643584B2 (en) * 2017-11-16 2023-05-09 Georgia Tech Research Corporation Incorporation of microencapsulated phase change materials into wet-spin dry jet polymeric fibers
EP3740197A4 (en) 2018-01-16 2021-11-10 Applied Materials, Inc. METAL OXIDE ENCAPSULATED COMPOSITIONS OF THE ACTIVE SUBSTANCE AND PROCESS FOR THEIR MANUFACTURING
CN109338135B (zh) * 2018-10-11 2020-07-14 西北工业大学 一种核壳结构Al@Ti-Al2O3相变蓄热复合材料及制备方法
RU2701030C1 (ru) * 2018-12-29 2019-09-24 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Способ получения полых кремнеземных нанокапсул
WO2020170029A2 (en) 2019-02-19 2020-08-27 Sol-Gel Technologies Ltd. Method for first-line treatment of rosacea
MX2021012434A (es) 2019-04-17 2022-01-19 Procter & Gamble Capsulas.
WO2020214878A1 (en) 2019-04-17 2020-10-22 The Procter & Gamble Company Methods of making capsules
JP7395612B2 (ja) 2019-04-17 2023-12-11 ザ プロクター アンド ギャンブル カンパニー カプセル
KR20220051385A (ko) 2019-08-27 2022-04-26 어플라이드 머티어리얼스, 인코포레이티드 약제 용해도 조절을 위한 증기상 코팅들
WO2021132729A1 (ja) * 2019-12-27 2021-07-01 花王株式会社 マイクロカプセルの製造方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
AU2021274996B2 (en) 2020-05-22 2026-04-09 Sol-Gel Technologies Ltd. Stabilized microcapsules, method of their preparation and uses thereof
TWI870622B (zh) 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
US11938349B2 (en) 2020-10-16 2024-03-26 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising capsules
US12077728B2 (en) 2020-10-16 2024-09-03 The Procter & Gamble Company Laundry care additive particles
HUE069038T2 (hu) 2020-10-16 2025-02-28 Procter & Gamble Mag/héj szerkezetû kapszulát tartalmazó vízoldékony egyedi csomagolású árucikk
JP7544969B2 (ja) 2020-10-16 2024-09-03 ザ プロクター アンド ギャンブル カンパニー カプセルを含む液体布地ケア組成物
US12458942B2 (en) 2020-10-16 2025-11-04 The Procter & Gamble Company Capsules
CN112143476B (zh) * 2020-10-21 2022-03-04 南京工业大学 一种采用微流场反应技术制备纳米包覆驱油剂的方法及装置
CN121797207A (zh) 2020-12-28 2026-04-07 花王株式会社 微胶囊
EP4269550A4 (en) * 2020-12-28 2025-03-26 Kao Corporation PROCESS FOR MANUFACTURING SILICA MICROCAPSULES
CN116806141A (zh) * 2020-12-29 2023-09-26 株式会社Lg生活健康 利用矿物质材料的有效成分稳定化方法
EP4408402A4 (en) 2021-09-30 2025-08-06 Applied Materials Inc LOW TEMPERATURE SILICON OXIDE COATING FOR PHARMACEUTICAL APPLICATIONS
CN116919939B (zh) * 2022-04-02 2026-02-03 南京毓浠医药技术有限公司 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途
US12275885B2 (en) * 2022-07-13 2025-04-15 King Fahd University Of Petroleum And Minerals Doped phase change material and method of preparation thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
ATE249196T1 (de) 1993-02-26 2003-09-15 Estee Lauder Inc Titandioxiddispersionen, kosmetische präparate und verfahren für ihre verwendung
US5401517A (en) 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5720949A (en) 1996-05-06 1998-02-24 Bristol-Myers Squibb Company Foamable cosmetic mask product
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
ES2216360T3 (es) 1998-02-06 2004-10-16 Seiwa Kasei Co., Ltd. Microcapsula con pared particular y su procedimiento de fabricacion.
US6099894A (en) 1998-07-27 2000-08-08 Frisby Technologies, Inc. Gel-coated microcapsules
DE1104287T1 (de) 1998-08-13 2001-12-20 Sol-Gel Technologies Ltd., Tel Aviv Verfahren zur herstellung von mit funktionalisierten molekülen beladene oxid-mikrokapseln und die daraus erhaltenen produkte
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
AU4775400A (en) 1999-05-25 2000-12-12 Sol-Gel Technologies Ltd. A method for obtaining photostable sunscreen compositions
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
ES2366886T1 (es) 2000-04-21 2011-10-26 Sol-Gel Technologies Ltd. Composición que presenta estabilidad de formulación potenciada y administración de ingredientes activos tópicos potenciado.
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
JP2007500590A (ja) 2003-07-31 2007-01-18 ゾル−ゲル テクノロジーズ エルティーディー． 活性成分が充填されたマイクロカプセル及びその製造方法
DE102004017221A1 (de) 2004-04-05 2005-10-20 Cognis Ip Man Gmbh O/W-Gel-Zusammensetzungen mit Estern des Pentaerythrits oder dessen Oligomeren
EP1750659A1 (de) 2004-04-05 2007-02-14 Cognis IP Management GmbH Wachmischung auf basis von partialglyceriden und pentaerythritestern
EA015815B1 (ru) * 2005-08-02 2011-12-30 Сол-Джел Текнолоджиз Лтд. Покрытие из оксида металла для водонерастворимых ингредиентов
WO2007092312A2 (en) 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
WO2008072239A2 (en) * 2006-12-12 2008-06-19 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
US20100047357A1 (en) 2007-02-01 2010-02-25 Sol-Gel Technologies Ltd. Compositions for topical application comprising a peroxide and retinoid
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
EP2158031B1 (en) 2007-05-08 2011-08-03 Givaudan SA Wax encapsulation
JP2011529392A (ja) * 2008-07-31 2011-12-08 ゾル−ゲル テクノロジー リミテッド 活性成分および金属酸化物シェルを含むマイクロカプセル、その製造方法およびその使用
BR112012012023A2 (pt) 2009-12-31 2016-05-17 Sol Gel Technologies Ltd processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021006615A1 (ko) * 2019-07-09 2021-01-14 주식회사 엘지생활건강 화장품용 캡슐
KR20210006866A (ko) * 2019-07-09 2021-01-19 주식회사 엘지생활건강 화장품용 캡슐
JP2022540598A (ja) * 2019-07-09 2022-09-16 エルジー ハウスホールド アンド ヘルスケア リミテッド 化粧品用カプセル
US12239722B2 (en) 2019-07-09 2025-03-04 Lg Household & Health Care Ltd. Capsule for cosmetics

Also Published As

Publication number Publication date
EP2467132A2 (en) 2012-06-27
JP5934107B2 (ja) 2016-06-15
ZA201203582B (en) 2013-01-30
MX344128B (es) 2016-12-06
AU2010337830B2 (en) 2013-10-03
US10512796B2 (en) 2019-12-24
EP2467132B1 (en) 2016-10-19
WO2011080741A3 (en) 2011-10-13
AU2010337830A1 (en) 2012-03-22
US20120202695A1 (en) 2012-08-09
MX2012006636A (es) 2012-07-10
CN102596186B (zh) 2017-08-11
US20180117369A1 (en) 2018-05-03
ES2611499T3 (es) 2017-05-09
EA201200347A1 (ru) 2012-07-30
CA2773544A1 (en) 2011-07-07
JP2013516404A (ja) 2013-05-13
BR112012012023A2 (pt) 2016-05-17
CN102596186A (zh) 2012-07-18
CA2773544C (en) 2019-02-12
WO2011080741A2 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
US12070629B2 (en) Core stabilized microcapsules, method of their preparation and uses thereof
US10512796B2 (en) Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) Core stabilized microcapsules, method of their preparation and uses thereof
JP6033859B2 (ja) コア−シェルマイクロカプセル含有安定化局所製剤
US20190015368A1 (en) Method of acne treatment by concomitant topical administration of benzoyl peroxide and tretinoin
JP6788066B2 (ja) 過酸化ベンゾイルおよびアダパレンを含む局所投与用組成物
CN110869013A (zh) 包含囊封的维甲酸的组合物
HK1169943B (en) Core stabilized microcapsules, method of their preparation and uses thereof
CN103945836A (zh) 包含阿曲汀的药物方法和局部用组合物

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000